Close Menu

NEW YORK — OpGen on Thursday reported a 54 percent increase in preliminary third quarter revenues as it consolidates its product portfolio following its acquisition of German diagnostics firm Curetis earlier this year.

For the three-month period ended September 30, OpGen expects revenues of $1.0 million versus $648,000 in the same quarter a year ago. The Gaithersburg, Maryland-based firm finished the third quarter with $10.4 million in cash.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.